Research Article
Pentraxin-3 Predicts Long-Term Cardiac Events in Patients with Chronic Heart Failure
Table 4
Univariate and multivariate Cox regression analysis of major adverse cardiovascular events.
| | HR | 95% CI | value |
| Univariate analysis | | | | Age | 2.609 | 1.371–4.992 | <0.001 | Males | 0.760 | 0.534–1.082 | 0.128 | Heart rate | 1.189 | 1.058–1.328 | 0.003 | NYHA class >II | 3.493 | 2.089–5.848 | <0.001 | PTX3 | 4.399 | 3.081–6.281 | <0.001 | cTnI | 1.591 | 1.296–1.954 | <0.001 | hsCRP | 1.248 | 1.043–1.492 | 0.016 | CHD | 0.778 | 0.548–1.218 | 0.278 | Diabetes mellitus | 1.013 | 0.978–1.048 | 0.477 | Hypertension | 0.923 | 0.521–1.622 | 0.773 | Hyperlipidemia | 1.022 | 0.989–1.055 | 0.193 | Current smoking | 1.018 | 0.948–1.091 | 0.568 | Aspirin | 1.091 | 0.793–1.501 | 0.594 | β-blockers | 0.780 | 0.314–1.864 | 0.526 | ACE-I/ARB | 0.962 | 0.710–1.385 | 0.962 | Diuretics | 0.990 | 0.975–1.006 | 0.226 | Multivariate analysis | | | | Age | 2.518 | 1.030–6.158 | 0.020 | PTX3 | 4.154 | 1.130–15.783 | 0.005 | cTnI | 1.808 | 1.208–2.686 | 0.008 | NYHA class >II | 3.018 | 1.818–4.998 | <0.001 |
|
|